Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

IgE, mast cells, basophils, and eosinophils.

Stone KD, Prussin C, Metcalfe DD.

J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S73-80. doi: 10.1016/j.jaci.2009.11.017. Review.

2.

Advances in mechanisms of asthma, allergy, and immunology in 2008.

Boyce JA, Broide D, Matsumoto K, Bochner BS.

J Allergy Clin Immunol. 2009 Mar;123(3):569-74. doi: 10.1016/j.jaci.2009.01.041. Review.

3.

An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.

Shiung YY, Chiang CY, Chen JB, Wu PC, Hung AF, Lu DC, Pan RL, Chang TW.

Immunobiology. 2012 Jul;217(7):676-83. doi: 10.1016/j.imbio.2011.11.006.

PMID:
22226669
4.

Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.

Eggel A, Baravalle G, Hobi G, Kim B, Buschor P, Forrer P, Shin JS, Vogel M, Stadler BM, Dahinden CA, Jardetzky TS.

J Allergy Clin Immunol. 2014 Jun;133(6):1709-19.e8. doi: 10.1016/j.jaci.2014.02.005.

5.

Comparable actions of omalizumab on mast cells and basophils.

Serrano-Candelas E, Martinez-Aranguren R, Valero A, Bartra J, Gastaminza G, Goikoetxea MJ, Martín M, Ferrer M.

Clin Exp Allergy. 2016 Jan;46(1):92-102. doi: 10.1111/cea.12668.

PMID:
26509363
7.

5. IgE, mast cells, basophils, and eosinophils.

Prussin C, Metcalfe DD.

J Allergy Clin Immunol. 2006 Feb;117(2 Suppl Mini-Primer):S450-6. Review.

PMID:
16455345
8.

Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils.

Song Y, Qu C, Srivastava K, Yang N, Busse P, Zhao W, Li XM.

J Allergy Clin Immunol. 2010 Dec;126(6):1208-17.e3. doi: 10.1016/j.jaci.2010.09.013.

9.

Mechanisms of IgE-mediated allergic reactions.

Bloebaum RM, Dharajiya N, Grant JA.

Clin Allergy Immunol. 2004;18:65-84. No abstract available.

PMID:
15042909
10.

[Treatment of allergic diseases with monoclonal anti-IgE antibody].

Morita Y.

Nihon Rinsho. 2001 Oct;59(10):2019-22. Review. Japanese.

PMID:
11676148
11.

Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge.

Christensen LH, Holm J, Lund G, Riise E, Lund K.

J Allergy Clin Immunol. 2008 Aug;122(2):298-304. doi: 10.1016/j.jaci.2008.05.026.

PMID:
18572230
12.

FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.

Safaralizadeh R, Soheili ZS, Deezagi A, Pourpak Z, Samiei S, Moin M.

Iran J Allergy Asthma Immunol. 2009 Dec;8(4):177-83. doi: 08.04/ijaai.177183.

13.

Reduced FcepsilonRI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy.

Oliver JM, Tarleton CA, Gilmartin L, Archibeque T, Qualls CR, Diehl L, Wilson BS, Schuyler M.

Int Arch Allergy Immunol. 2010;151(4):275-84. doi: 10.1159/000250436.

14.

IgE receptors.

Novak N, Kraft S, Bieber T.

Curr Opin Immunol. 2001 Dec;13(6):721-6. Review.

PMID:
11677096
15.

Rapid polyclonal desensitization with antibodies to IgE and FcεRIα.

Khodoun MV, Kucuk ZY, Strait RT, Krishnamurthy D, Janek K, Lewkowich I, Morris SC, Finkelman FD.

J Allergy Clin Immunol. 2013 Jun;131(6):1555-64. doi: 10.1016/j.jaci.2013.02.043.

16.

Omalizumab-induced reductions in mast cell Fce psilon RI expression and function.

Beck LA, Marcotte GV, MacGlashan D, Togias A, Saini S.

J Allergy Clin Immunol. 2004 Sep;114(3):527-30.

PMID:
15356552
17.

Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.

Mirkina I, Schweighoffer T, Kricek F.

Immunol Lett. 2007 Apr 15;109(2):120-8.

PMID:
17368811
18.

Review: Diagnostic and therapeutic applications of rat basophilic leukemia cells.

Rashid A, Sadroddiny E, Ye HT, Vratimos A, Sabban S, Carey E, Helm B.

Mol Immunol. 2012 Oct;52(3-4):224-8. doi: 10.1016/j.molimm.2012.05.019. Review.

PMID:
22750069
19.

Anti-IgE as a mast cell-stabilizing therapeutic agent.

Chang TW, Shiung YY.

J Allergy Clin Immunol. 2006 Jun;117(6):1203-12; quiz 1213. Review.

PMID:
16750976
20.

Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.

Okayama Y, Kashiwakura J, Sasaki-Sakamoto T, Matsumoto K, Hashimoto N, Ohmori K, Kawakami T, Saito H, Ra C.

Ann Allergy Asthma Immunol. 2012 Mar;108(3):188-94. doi: 10.1016/j.anai.2012.01.009.

PMID:
22374203
Items per page

Supplemental Content

Support Center